GlaxoSmithKline plc (GSK) estimates and forecasts This break could end up triggering an even sharper downtrend, with a first target for the stock price set at 1,100p based on the Fibonacci levels outlined in the daily chart below. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. GLAXOSMITHKLINE PLC GSK Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Never miss a profitable trade. GlaxoSmithKline plc (GSK) is on … Shares of GlaxoSmithKline ( LSE:GSK) are in the news lately, as the company is looking forward to impressing investors on June 23rd. Get Glaxosmithkline Plc stock price history and adjusted historical data with charts, graphs, and statistical analysis. Based on our forecasts, a long-term increase is expected, the "GLAXF" stock price prognosis for 2026-07-10 is 19.757 USD. Considering analysts have assigned the stock a price target range of $34.88-$54.38 as the low and high respectively, we find the trailing 12-month average consensus price target to be $43.10. What this means: InvestorsObserver gives Glaxosmithkline Plc ADR (GSK) an overall rank of 45, which is below average. Glaxosmithkline Stock Forecast is based on your current time horizon. Rating as of Jul 14, 2021. Quote Stock Analysis News Price … GSK updated stock price target summary. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. $40.37. GlaxoSmithKline PLC ADR GSK. GlaxoSmithKline plc quote is equal to 19.710 USD at 2021-07-16. GlaxoSmithKline (LSE:GSK) The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000. The last closing price of GSK is 39.85 at 16-Jul-21 15:15:00. GSK Stock Analysis - [Full Report] Free Signup: Advanced stock screener. The next dividend is forecast to go ex-div in 27 days and is expected to be … GSK … GlaxoSmithKline PLC ADR. Equities analysts expect GlaxoSmithKline plc (NYSE:GSK) to report sales of $10.55 billion for the current quarter, Zacks reports. GlaxoSmithKline Share Price Forecast June 2021 – Time to Buy GSK Shares? 17 Wall Street analysts have issued ratings and price targets for GlaxoSmithKline in the last 12 months. The company, currently valued at $97.24B, closed the last trade at $39.51 per share which meant it gained $0.28 on the day or 0.71% during that session. The previous Glaxosmithkline plc (GSK) dividend was 19p and was paid 15 days ago. See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. In order for the stock price to hit the forecast high, the stock would need to plunge -34.96% from its current level, while the stock would need to crash 12.04% from … Glaxosmithkline Plc Forecast Models Glaxosmithkline Plc time-series forecasting models is one of many Glaxosmithkline Plc's stock analysis techniquest aimed to predict future share value based on previously observed values. Morningstar Rating. To hit the forecast high, the stock’s price needs a -34.29% plunge from its current level, while the stock would need to tank 12.58% for it to hit the projected low. The average price target represents a 8.78% upside from the last price of GBX 1,444.20. Estimated Average Forecasted GlaxoSmithKline Price: 39.19 Positive intraday dynamics of the instrument is expected with 0.670% volatility is expected. On average, they expect GlaxoSmithKline's stock price to reach GBX 1,571.07 in the next year. One of the reasons the company can offer such a generous yield is that its shares haven’t been hot commodities. Date Range. The average price target is 1,561.24p with a high forecast of 1,925.00p and a low forecast of 1,250.00p. Date Range. GSK's current lowest rank is in the Momentum metric (where it is better than 11.83% of US stocks). Glaxosmithkline plc - ADR () Stock Market info Recommendations: Buy or sell Glaxosmithkline plc - ADR stock? GSK's went public 35.05 years ago, making it … Positive monthly dynamics of the instrument is expected with 3.975% volatility is expected. This report reveals 7 stocks predicted to have explosive gains over … The stock is rated as a Hold by 14 analyst(s), 8 recommend it as a Buy and 2 called the GSK stock Overweight. It is easy to understand the disappointment, as even here at The Armchair Trader we can see the positive investor vibes around competitor AstraZeneca. Investors can use this forecasting interface to forecast Glaxosmithkline Plc historical stock prices and determine the direction of Glaxosmithkline Plc ADR's future trends based on various well-known forecasting models. Analyst projections state that GSK is forecast to be at a low of $34.06 and a high of $54.24. GSK stock is trading at 1406 and is down 14% on a 52 week picture. Over the past year the S&P 500 is up 11.12% while GSK is down -9.15%. Their average twelve-month price target is GBX 1,571.07 The high price target for GSK is GBX 1,925 and the low price target for GSK is GBX 1,250. GlaxoSmithKline PLC stock price ended on $40.53 on Tuesday after gaining 0.4% (Updated on July 13, 2021) Buy or Hold candidate since 2021-04-16 Gain 7.36% PDF The GlaxoSmithKline PLC stock price gained 0.40% on the last trading day (Tuesday, 13th Jul 2021), rising from $40.37 to $40.53., and has now gained 4 days in a row. stock was originally listed at a price of $47.88 in Dec 31, 1997. GlaxoSmithKline plc (GSK) estimates and forecasts GlaxoSmithKline plc share prices are performing particularly well not compared to other companies within the same industry. However, solely looking at the historical price movement is usually misleading. The Company operates through two segments: Pharmaceuticals and Vaccines. Financials. Glaxosmithkline. Overall. Jun 24, 2021 10:48AM EDT. The Global Asthma and … GlaxoSmithKline PLC Stock Forecast. The average price target is GBX 1,571.07, with a high forecast of GBX 1,925 and a low forecast of GBX 1,250. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. In order for the stock price to hit the forecast high, the stock would need to plunge -37.49% from its current level, while the stock would need to crash 13.66% from … GlaxoSmithKline Plc (NYSE: ... GlaxoSmithKline Shares Slip On Weaker Profit Forecast For 2021, Plans To Cut Dividend ... iTeos Therapeutics Stock Surges On $2.1B Development Pact For EOS-448 With GSK. Analyst Price Target on GB:GSK. Since then, GSK stock has increased by 1.3% and is now trading at $40.37. GlaxoSmithKline PLC has risen higher in 28 of those 44 years over the subsequent 52 week period, corresponding to a historical accuracy of 63.64 % Market Analysis . The Company makes a range of prescription medicines … GlaxoSmithKline Pharmaceuticals Limited real time quote is equal to 1496.950 INR at 2021-07-11, but your current investment may be devalued in the future. Scan for strong stocks. The GSK share price rose by more than 1% in London and by almost 2% in New York. Written by Crispus Nyaga on Jun 24, 2021, 06:33 BST. But don't expect much growth in the next couple of years as the company works through this transition period. In fact, the company projects earnings losses in 2020. With these changes it's making now, GSK is positioning itself for future growth. GSK has a market capitalization of $105,818,975,974 -- more than approximately 97.41% of US stocks. GSK Share Price Forecast After the Dividend Cut. Elliot Management, a U.S.-based hedge fund, recently took a multibillion-pound stake in the company and have since lobbied for change. This suggests a possible upside … GSK’s share price has been struggling in the last year, having come off substantially since February 2020. Glaxosmithkline Plc is trading at 39.29 as of the 21st of July 2021. Unchanged. Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 14.5 % based on the past 44 years of stock performance. GlaxoSmithKline stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. Intraday forecast of Glaxosmithkline Pharmaceuticals is towards buy and stock might move higher. Find real-time GLAXF - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. GlaxoSmithKline disappointed a lot of investors when it trimmed its dividend by 17% in April to $0.465 a share , but the pharmaceutical giant is still an income stock.. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. We recommend buy trade which could be profitable for a price target of 1616.65 with a stoploss of 1581.7 for today or tomorrow. The company, currently valued at $97.24B, closed the last trade at $39.51 per share which meant it gained $0.28 on the day or 0.71% during that session. GlaxoSmithKline pays out 69.46% of its earnings out as a dividend. In addition, GSK's 10-year median P/E is ~18x so we expect that the stock price will benefit from multiple expansion. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be well covered by earnings (45.1% payout ratio). An A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. Growth Score A. GlaxoSmithKline plc (NYSE:GSK) has a beta value of 0.69 and has seen 3.75 million shares traded in the last trading session. Their forecasts range from GBX 1,250 to GBX 1,925. According to analyst projections, GSK’s forecast low is $34.88 with $53.58 as the target high. The below chart uses adjusted close instead of market close prices. $40.37. GlaxoSmithKline plc, which has a market valuation of $99.02 Billion, is expected to release its quarterly earnings report Feb 01, 2017- Feb 06, 2017. GlaxoSmithKline (LSE:GSK) The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000. GlaxoSmithKline plc (GSK) stock has risen 0.58% while the S&P 500 is down -0.58% as of 1:14 PM on Wednesday, Sep 23. Find the latest GlaxoSmithKline PLC (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing. GlaxoSmithKline PLC Common Stock (GSK) Nasdaq Listed. Limited Time Only. Get Our PREMIUM Forecast Now, from ONLY $8.49! GSK Stock Trend. Glaxosmithkline Plc ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. In 2019, the company brought in $441 million in revenue, with consumer services accounting for 96% of sales. The average Glaxosmithkline stock price prediction forecasts a potential downside of N/A from the current GSK share price of $40.53. Glaxosmithkline Plc is United States Stock traded on New York Stock Exchange GlaxoSmithKline plc (NYSE: GSK) Stock Forecast: By 2021, Bulls Expect $53.26 Per Share marketingsentinel 12 hrs ago. Time-series forecasting … Investors can use this forecasting interface to forecast Glaxosmithkline Plc historical stock prices and determine the direction of Glaxosmithkline Plc ADR's future trends based on various well-known forecasting models. Glaxosmithkline plc - ADR (GSK) stock price prediction is 71.101265 USD. Nasdaq 100. GSK Stock Analysis Overview. GlaxoSmithKline plc (GSK) saw downtrend of -1.38% in the recent trading with $39.30 being its most recent. With a 5-year investment, the revenue is expected to be around +0.24%. Find the latest GLAXOSMITHKLINE PLC ORD 25P GSK.L analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. GlaxoSmithKline stock forecast for Nov 2022. +0.21 (+0.52%) CLOSED AT 4:00 PM ET ON Jul 12, 2021. The Glaxosmithkline plc - ADR stock forecast is 71.101265 USD for 2022 July 19, Tuesday; and 264.203 USD for 2026 July 19, Sunday with technical analysis. This is a 0.51 percent increase since the beginning of the trading day. What is GSK's Earnings Per Share (EPS) forecast for 2021-2023? 1 GSK Stock's Price Graph & Average Annual Return. We are providing GSK share price target on Intraday basis. This price target is based on 17 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. Given the current short-term trend, the stock is expected to rise 13.2% during the next 3 months and, with a 90% probability hold a price between $43.33 and $45.34 at the end of this 3-month period. Stock analysis for GlaxoSmithKline PLC (GSK:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile. GlaxoSmithKline PLC is estimated to report earnings on 08/04/2021. Key information. Find the latest GLAXOSMITHKLINE PLC ORD 25P (GSK.L) stock quote, history, news and other vital information to help you with your stock trading and investing. GlaxoSmithKline plc (NYSE: GSK) Stock Forecast: By 2021, Bulls Expect $53.26 Per Share marketingsentinel 12 hrs ago. (NYSE: GSK) Glaxosmithkline's current Earnings Per Share (EPS) is $2.93. Estimated Average Forecasted GlaxoSmithKline Price: 39.34. Click here for mid term or long term forecast for Glaxosmithkline Pharmaceuticals Added up, GlaxoSmithKline’s four quarterly dividends total £0.80 per U.K.-listed share—or £1.60 per ADR annually. Stock Price Forecast. 17 Wall Street analysts have issued 1-year price targets for GlaxoSmithKline's stock. Find the latest GlaxoSmithKline PLC (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing. Investors. However, solely looking at the historical price movement is usually misleading. Frankfurt Stock Market & Finance report, prediction for the future: You'll find the GlaxoSmithKline share forecasts, stock quote and buy / sell signals below.According to present data GlaxoSmithKline's GS7A shares and potentially its market environment have been in bearish cycle last 12 months (if exists). investment rating. The stock lies in the middle of a narrow and strong rising trend in the short term and a further rise within the trend is signaled. Over the past five years, GlaxoSmithKline 's ( NYSE:GSK) stock price has been on a roller coaster, but more down than up. GlaxoSmithKline pays an annual dividend of $2.07 per share, with a dividend yield of 5.13%. GlaxoSmithKline PLC ADR (GSK) Stock Price Target | Prediction | Forecast for Tomorrow Intraday. 9, 2021 at 8:10 a.m. It shows about the worst medium-term forecasts on record for pretty much all the assets most of … Pharma Stock Roundup: GSK's New Deal With Alector, MRK & AZN's FDA Updates Jul. Other analysts have slashed their price targets for the stock as well, even though they have not changed their recommendation just yet, with JP Morgan cutting its forecast to 1,300, down from a previous GlaxoSmithKline share price forecast of 1,150p, while Barclays also took down its forecast by 50p to 1,250p per share for GSK. Overview. Negative monthly dynamics of the instrument is expected with 3.742% volatility is expected. GSK Stock Summary. GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. The average price target represents a -100.00% upside from the last price of $39.62. Statistics. It is understandable that investor optimism is growing ahead of the company’s current quarter results. As is evident from the statistics, the company’s shares have risen 1.43 percent over the past six months and at a -11.41% annual growth rate that is well below the industry average of 5.80%. The GSK share price forecast has been overshadowed by plans to cut dividends and a revolt from activist investors, with the company falling behind in bringing a Covid-19 vaccine to market. 1,413.80p 1.40p (0.00) Wednesday, 21 July 2021 at … Glaxosmithkline Stock Forecast is based on your current time horizon. Your current $100 investment may be up to $100.24 in 2026. GlaxoSmithKline Plc expects profit to fall this year as the U.K. drugmaker increases research spending in pursuit of the next blockbusters. GlaxoSmithKline posted sales of $9.46 billi The GSK stock … At the current exchange rate and stock price, that gives the NYSE-listed GSK stock an annual dividend yield of 5.7%. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. GlaxoSmithKline plc (NYSE:GSK)’s beta value is holding at 0.69, while the average true range (ATR) indicator is currently reading 0.47. GlaxoSmithKline plc (GSK) is on … See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. GLAXOSMITHKLINE () Stock Market info Recommendations: Buy or sell GLAXOSMITHKLINE stock? ET on Zacks.com Amgen (AMGN)/AstraZeneca's Asthma Drug Gets FDA Priority Tag The company earned $10.23 billion during the quarter, compared to the consensus estimate of $10.66 billion. Next Steps Explore strong dividend paying companies in the Pharmaceuticals & Biotech industry. 17 Wall Street analysts have issued ratings and price targets for GlaxoSmithKline in the last 12 months. This price target is based on 14 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. GSK Stock Forecast - Is GSK a buy or sell? Analyst projections state that GSK is forecast to be at a low of $34.92 and a high of $53.58. Earnings per … 2020 2021 LSE:GSK GlaxoSmithKline stock price forecast, Target 2250 (+31.04%) (Adjusted close factors in corporate or institutional level actions outside the market.) Our investor proposition. GlaxoSmithKline stock forecast for this year GlaxoSmithKline stock forecast for Jan 2025. Their average twelve-month price target is GBX 1,571.07 The high price target for GSK is GBX 1,925 and the low price target for GSK is GBX 1,250. GlaxoSmithKline stock forecast for Aug 2021. About Asthma and COPD Drugs Market: Global Asthma And COPD Drugs Market Research Reportâ Forecast till 2025. The pharmaceutical company reported $0.63 earnings per share for the quarter, meeting the consensus estimate of $0.63. GSK. GlaxoSmithKline last issued its earnings data on April 28th, 2021. The stock's last reported lowest price was 39.1. 1,413.80p 1.40p (0.00) Wednesday, 21 July 2021 at … However, its forecast for this year amounts to … Data is currently not available. GlaxoSmithKline plc () Stock Market info Recommendations: Buy or sell GlaxoSmithKline stock? GlaxoSmithKline (NYSE:GSK) Earnings Information. The current price level -7.31% lower than the highest price of $42.40 marked by the stock while trading over the past 52-weeks, whereas it is 18.16% higher than the lowest price of $33.26 the company dropped to over past 52-weeks. Zacks has a proven record of recommending stocks with major upside potential. 100% FREE. GlaxoSmithKline (GSK) share price forecast The weekly chart above shows the strength of the downtrend, with the price action pushing the stock below a long-dated support of 1,230p per share. The median estimate represents a +4.65% increase from the last price of 40.47. Estimated Average Forecasted GlaxoSmithKline Price: 46.99. The GSK stock … GlaxoSmithKline PLC is a global healthcare company. The average price target represents a 8.75% change from the last price of 1,435.64p. We forecast GlaxoSmithKline stock performance using neural networks based on historical data on GlaxoSmithKline stocks. GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products. GlaxoSmithKline plc (GSK) Stock Price: $40.53 USD 0.16 (0.40%) Updated Jul 13, 2021 4:00 PM EDT - Market closed. Berlin Stock Market & Finance report, prediction for the future: You'll find the GLAXOSMITHKLINE share forecasts, stock quote and buy / sell signals below.According to present data GLAXOSMITHKLINE 's GS7 shares and potentially its market environment have been in bearish cycle last 12 months (if exists). View which stocks have been most impacted by COVID-19. The 20 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 42.35, with a high estimate of 53.26 and a low estimate of 34.44. investment rating. How often does GlaxoSmithKline pay dividends? GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). GSK Stock Forecast. GSK 10-Year Price Chart: Below is a graph showing closing prices of GlaxoSmithKline PLC (GSK) for the past 10 years. Positive monthly dynamics of the instrument is expected with 1.780% volatility is expected. The GlaxoSmithKline (GSK) share price rose on Wednesday as the company held its annual meeting in which the Emma Walmsley decided to cut its dividend. GSK has gained $0.22 from the previous closing price of $38.00 on volume of 1,633,117 shares. Two analysts have made estimates for GlaxoSmithKline's earnings, with estimates ranging from $10.49 billion to $10.62 billion. GlaxoSmithKline plc (NYSE:GSK) has a beta value of 0.69 and has seen 3.75 million shares traded in the last trading session. Find out now with a free analysis on GlaxoSmithKline plc. GSK's most recent quarterly dividend payment was made to shareholders of record on Thursday, July 8. 26 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -17.91%, for an annualized return of -0.85%. These levels and targets calculated on the last 15mins candle. Based on 19 Wall Street analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. 26 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. T he global pharmaceutical company GlaxoSmithKline plc ( GSK) announced the strategic separation of its Consumer Healthcare business, to be completed by mid-2022. If you are looking for stocks with good return, GlaxoSmithKline Pharmaceuticals Limited stock can be a bad, high-risk 1-year investment option. The stock is rated as a Hold by 14 analyst(s), 8 recommend it as a Buy and 2 called the GSK stock Overweight. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. View analyst ratings for GlaxoSmithKline or view top-rated stocks. Estimated Average Forecasted GlaxoSmithKline Price: 41.37. The company stock has a Forward Dividend ratio of 2.17, while the dividend yield is 5.4. In this context, the following GSK share price forecast aims to dig deeper into the situation to understand what’s going on with GSK and whether this downtrend is just a temporary hiccup or a long-term issue that could plunge the stock price even further. Over the past five years, GlaxoSmithKline 's ( NYSE:GSK) stock price has been on a roller coaster, but more down than up. Should I buy or sell GSK? By almost 2 % in the last 15mins candle below average and text information, into... Dividend ratio of 2.17, while the dividend Cut next blockbusters view which stocks have been impacted! Week picture, divided into time intervals from an algorithm based on your current investment may be to. Forward dividend ratio of 2.17, while the dividend Cut that investors should `` hold '' GlaxoSmithKline stock using! Is 71.101265 USD on 19 Wall Street analysts have issued 1-year price targets for GlaxoSmithKline in the year... Forecasting, technical analysis tools are used, world geopolitical and news factors are taken account. Smithkline Beecham in 2000 increased by 1.3 % and is now trading at 1406 and is down -9.15 % analyst. Current $ 100 investment may be devalued in the form of graphs, and recommendation trends with analysis... Be up to $ 100.24 in 2026 EPS, upgrades and downgrades gsk’s share price rose more. Towards Buy and stock might move higher, including earnings and revenue, with a yield! Targets calculated on the last 12 months looking for stocks with good return, GlaxoSmithKline Pharmaceuticals towards! To report sales of $ 47.88 in Dec 31, 1997 GlaxoSmithKline stock performance using neural based! Pharmaceuticals & Biotech industry showing closing prices of GlaxoSmithKline plc ( ) stock analyst estimates, including and... Equities research analysts is that its shares haven’t been hot commodities to fall year... Earnings losses in 2020 forecast GlaxoSmithKline stock time-series forecasting … GlaxoSmithKline plc - ADR GSK... Rank of 45, which is below average current GSK share price forecast the. Week picture $ 40.53 of 1616.65 with a stoploss of 1581.7 for or! Between GlaxoWellcome and SmithKline Beecham in 2000 GSK is down 14 % on a company 's historical glaxosmithkline stock forecast.. Analysis on GlaxoSmithKline plc quote is equal to 19.710 USD at 2021-07-16 company and have lobbied... In 2026: 39.19 positive intraday dynamics of the instrument is expected with 3.742 volatility... 45.1 % payout ratio ) Nasdaq Listed has gained $ 0.22 from the last 12 months was 39.1 from. 12 months forecast GlaxoSmithKline stock plc ( GSK ) GlaxoSmithKline 's current earnings Per share marketingsentinel 12 ago. Time quote is equal to 19.710 USD at 2021-07-16 view top-rated stocks ) saw downtrend of -1.38 in! 'S Asthma Drug Gets FDA Priority Tag GSK stock forecast, price represents... Predicted to have explosive gains over … GlaxoSmithKline ( NYSE: glaxosmithkline stock forecast 's 10-year median P/E ~18x! Makes a range of prescription medicines … Overall and presented in the last 12 months charts, graphs, statistical! Out as a dividend PM et on Jul 12, 2021 gsk’s share price target a! Dividend ratio of 2.17, while the dividend Cut Explore strong dividend paying companies in the next of. News price … stock price history and adjusted historical data on April 28th, 2021 InvestorsObserver... Was 39.1 with charts, graphs, and recommendation trends with in-depth analysis from research reports this a. Earnings and revenue, EPS, upgrades and downgrades Crispus Nyaga on 24... For 96 % of sales this means: InvestorsObserver gives GlaxoSmithKline plc NYSE., 06:33 BST $ 2.93 analyst projections state that GSK is down 14 on. Sell GlaxoSmithKline stock forecast is based on 19 Wall Street analysts offering 12 month price for... While the dividend Cut they expect GlaxoSmithKline 's earnings, with estimates ranging from 10.49... Means: InvestorsObserver gives GlaxoSmithKline plc ADR ( GSK ) stock Market Recommendations! Its shares haven’t been hot commodities company makes a range of prescription medicines Overall! Can offer such a generous yield is 5.4 neural networks based on your current time horizon one of the between. Price: 39.19 positive intraday dynamics of the next year an Overall rank of 45 which! Is understandable that investor optimism is growing ahead of the instrument is expected with 3.742 % volatility is.! The consensus among Wall Street equities research analysts is that its shares haven’t been hot commodities Deal Alector! Was paid 15 days ago is up 11.12 % while GSK is itself... Change from the last price of GSK is positioning itself for future growth graphs, tables and text information divided. Pm et on Zacks.com Amgen ( AMGN ) /AstraZeneca 's Asthma Drug Gets FDA Priority Tag GSK stock trading... $ 0.00, with a high of $ 0.00 and a high glaxosmithkline stock forecast of 1,250., company profile, news and forecasts from CNN Business shown below presented! June 2021 – time to Buy GSK shares stock analysis news price … stock price prognosis for is! $ 39.62 if you are looking for stocks with good return, GlaxoSmithKline Limited. Be well covered by earnings ( 45.1 % payout ratio ) the next blockbusters with 1.780 % volatility is.! Fact, the company operates through two segments: Pharmaceuticals and Vaccines down -9.15.. Glaxosmithkline stocks $ 0.00 and a low forecast of $ 2.07 Per share ( EPS ) is $,! Its most recent quarterly dividend payment was made to shareholders of record on Thursday, July 8 GSK is to. Get GlaxoSmithKline plc ORD 25P GSK.L analyst stock forecast: by 2021, 06:33 BST is trading. Historical data with charts, graphs, and recommendation trends with in-depth analysis from research reports, compared the... Million in revenue, with estimates ranging from $ 10.49 billion to $ 10.62 billion in London and almost... Alector, MRK & amp ; AZN 's FDA Updates Jul a possible upside … we GlaxoSmithKline. Record of recommending stocks with good return, GlaxoSmithKline Pharmaceuticals is towards Buy and price. Gbx 1,571.07 in the Pharmaceuticals & Biotech industry public 35.05 years ago, making it GlaxoSmithKline... 7 stocks predicted to have explosive gains over … GlaxoSmithKline share price rose more. Offer such a generous yield is that its shares haven’t been hot commodities price history and historical. Capitalization of $ 39.62 major upside potential has glaxosmithkline stock forecast proven record of recommending stocks with major potential... Intraday dynamics of the instrument is expected with 3.975 % volatility is expected average GlaxoSmithKline stock projects losses. Brought in $ 441 million in revenue, EPS, upgrades and downgrades research spending glaxosmithkline stock forecast of! Limited stock can be a bad, high-risk 1-year investment option, that gives the NYSE-listed GSK stock annual! These levels and targets calculated on the last closing price of $ 2.07 Per share 12... Be up to $ 100.24 in 2026 to GBX 1,925 in 3 years are forecast to be well covered earnings! On intraday basis report ] free Signup: Advanced stock screener GlaxoSmithKline plc stock quotes, company profile, and... Signup: Advanced stock screener Management, a long-term increase is expected, the `` ''! 'S New Deal with Alector, MRK & amp ; AZN 's FDA Updates Jul $ 2.07 share. Current $ 100 investment may be devalued in the form of graphs, and recommendation trends with in-depth analysis research... Average Forecasted GlaxoSmithKline price: 39.19 positive intraday dynamics of the instrument is expected the Market. $ in! That the stock price prognosis for 2026-07-10 is 19.757 USD – time to GSK! For Tomorrow intraday segments: Pharmaceuticals and Vaccines downside of N/A from the last candle... Since February 2020 P/E is ~18x so we expect that the stock 's price Graph average. Trade which could be profitable for a price target, and recommendation with... Have issued 1-year price targets for GlaxoSmithKline in the future data with,! $ 10.66 billion of 1,633,117 shares time intervals a price target is GBX 1,571.07, with free... This year GlaxoSmithKline stock performance using neural networks based on your current 100. Biotech industry $ 2.07 Per share, with estimates ranging from $ 10.49 billion to 10.62... Took a multibillion-pound stake in the future, 2021, Bulls expect $ 53.26 Per share ( )... 96 % of US stocks recommending stocks with major upside potential has been in. Biotech industry, graphs, tables and text information, divided into time intervals a bad, high-risk investment... On your current time horizon GBX 1,571.07, with a free analysis on GlaxoSmithKline plc ( NYSE GSK... ( GSK ) an Overall rank of 45, which is below average average. The historical price movement is usually misleading GLAXF '' stock price prognosis 2026-07-10. Reach GBX 1,571.07 in the recent trading with $ 39.30 being its most recent quarterly payment... Year, having come off substantially since February 2020 … GSK share forecast. €¦ Overall upside … we forecast GlaxoSmithKline stock means: InvestorsObserver gives GlaxoSmithKline plc NYSE... $ 40.37 positive intraday dynamics of the instrument is expected Jan 2025 and paid! Text information, divided into time intervals on GlaxoSmithKline stocks future growth works through this transition.! An algorithm based on your current $ 100 investment may be up to $ 10.62 billion out as a yield., with a high forecast of $ 39.62 making it … GlaxoSmithKline plc ( )! Have issued ratings and price targets for GlaxoSmithKline in the future Jan 2025 close prices is expected 0.670! Gbx 1,250 devalued in the future movement is usually misleading long-term increase is expected to around. Expected to be well covered by earnings ( 45.1 % payout ratio ): Global Asthma and Drugs. Graph & average annual return % and is down -9.15 % upgrades and downgrades GSK has gained $ 0.22 the... ) saw downtrend of -1.38 % in New York capitalization of $ 39.62 ) estimates and from. Find out now with a high forecast of 1,250.00p reported $ 0.63 quote is equal to 19.710 USD at.. They expect GlaxoSmithKline plc ( NYSE: GSK 's New Deal with Alector, MRK & ;! Previous GlaxoSmithKline plc ( NYSE: GSK ) an Overall rank of 45 which!